Sunitinib Treatment Of Renal Adjuvant Cancer (S-trac): A Randomized Double-blind Phase 3 Study Of Adjuvant Sunitinib Vs. Placebo In Subjects At High Risk Of Recurrent Rcc
收藏DataCite Commons2025-12-12 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006825/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
To compare the disease free survival time and safety of sunitinib with placebo in adjuvant
treatment patients at high risk of recurrent kidney cancer after surgery.
提供机构：
Vivli
创建时间：
2021-04-02
